Investors in Elevance Health, Inc. ELV need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $270Call had some of the highest implied ...

GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the ...

Elevance Health, Inc. (NYSE:ELV – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports.

Anthem offers Medicare Advantage plans providing Original Medicare Part A and Part B coverage, plus other benefits like ...

A Medicare Supplement—or Medigap—plan is an insurance plan that helps pay for gaps in coverage from Original Medicare. Anthem ...

Shares of Elevance Health Inc. ELV slid 1.24% to $391.22 Tuesday, on what proved to be an all-around positive trading session ...

This was the stock's second consecutive day of gains.

Elevance Health has inked a deal with Verily to acquire its stop-loss insurance unit, Granular Insurance Company, a ...

Multi-national corporations, home-grown companies, industry groups, advocacy organizations, local government, lobbying firms ...

Within brain health, the robust demand for AD-detect blood tests for assessing Alzheimer's disease risk drives solid growth ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.